Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)

China flag China · Delayed Price · Currency is CNY
12.71
-0.27 (-2.08%)
Jun 11, 2026, 1:55 PM CST
Market Cap7.63B -6.7%
Revenue (ttm)2.10B -3.4%
Net Income452.67M -14.0%
EPS0.77 -14.5%
Shares Out 587.57M
PE Ratio16.85
Forward PEn/a
Dividend0.50 (3.93%)
Ex-Dividend DateJun 4, 2026
Volume1,272,010
Open12.97
Previous Close12.98
Day's Range12.65 - 12.99
52-Week Range12.59 - 17.38
Beta0.20
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHE:002275

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China and internationally. The company offers three gold particles, Guilin watermelon frost, watermelon frost lozenges, throat clearing spray, Naomaitai capsules, vertigo tablets, Xuanyunning granules, Gejie dingchuan capsule, compound panax notoginseng stomachache capsule, compound panax notoginseng stomach pain tablets, Sanqi xueshangning capsules, Sanqi xueshangning powder, compound luo han guo qing fei granule... [Read more]

Sector Healthcare
Founded 1985
Employees 2,556
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002275
Full Company Profile

Financial Performance

In 2025, SHE:002275's revenue was 2.05 billion, a decrease of -6.76% compared to the previous year's 2.19 billion. Earnings were 433.13 million, a decrease of -16.95%.

Financial Statements